BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND KDM5A, RBBP2, 5927, JARID1A, ENSG00000073614 AND Prognosis
7 results:

  • 1. The pediatric leukemia oncoprotein NUP98-kdm5a induces genomic instability that may facilitate malignant transformation.
    Domingo-Reinés J; Montes R; Garcia-Moreno A; Gallardo A; Sanchez-Manas JM; Ellson I; Lamolda M; Calabro C; López-Escamez JA; Catalina P; Carmona-Sáez P; Real PJ; Landeira D; Ramos-Mejia V
    Cell Death Dis; 2023 Jun; 14(6):357. PubMed ID: 37301844
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pharmacological inhibition of kdm5a for cancer treatment.
    Yang GJ; Wu J; Miao L; Zhu MH; Zhou QJ; Lu XJ; Lu JF; Leung CH; Ma DL; Chen J
    Eur J Med Chem; 2021 Dec; 226():113855. PubMed ID: 34555614
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Modeling and targeting of erythroleukemia by hematopoietic genome editing.
    Iacobucci I; Qu C; Varotto E; Janke LJ; Yang X; Seth A; Shelat A; Friske JD; Fukano R; Yu J; Freeman BB; Kennedy JA; Sperling AS; Zheng R; Wang Y; Jogiraju H; Dickerson KM; Payne-Turner D; Morris SM; Hollis ES; Ghosn N; Haggard GE; Lindsley RC; Ebert BL; Mullighan CG
    Blood; 2021 Mar; 137(12):1628-1640. PubMed ID: 33512458
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.
    Schmoellerl J; Barbosa IAM; Eder T; Brandstoetter T; Schmidt L; Maurer B; Troester S; Pham HTT; Sagarajit M; Ebner J; Manhart G; Aslan E; Terlecki-Zaniewicz S; Van der Veen C; Hoermann G; Duployez N; Petit A; Lapillonne H; Puissant A; Itzykson R; Moriggl R; Heuser M; Meisel R; Valent P; Sexl V; Zuber J; Grebien F
    Blood; 2020 Jul; 136(4):387-400. PubMed ID: 32344427
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Genetic aberrations and new treatment strategies for pediatric acute myeloid leukemia].
    Shiba N
    Rinsho Ketsueki; 2018; 59(10):2260-2267. PubMed ID: 30305534
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. NUP98/jarid1a is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern.
    de Rooij JD; Hollink IH; Arentsen-Peters ST; van Galen JF; Berna Beverloo H; Baruchel A; Trka J; Reinhardt D; Sonneveld E; Zimmermann M; Alonzo TA; Pieters R; Meshinchi S; van den Heuvel-Eibrink MM; Zwaan CM
    Leukemia; 2013 Dec; 27(12):2280-8. PubMed ID: 23531517
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.